These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 9815774

  • 1. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L, Liu L, van Meyel D, Cairncross G, Forsyth P, Kimmel D, Jenkins RB, Lassam NJ, Hogg D.
    Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774
    [Abstract] [Full Text] [Related]

  • 2. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y, Yoshimoto T, Sekiya T.
    Oncogene; 1995 Nov 16; 11(10):2145-9. PubMed ID: 7478535
    [Abstract] [Full Text] [Related]

  • 3. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
    Soufir N, Bressac-de Paillerets B, Desjardins L, Lévy C, Bombled J, Gorin I, Schlienger P, Stoppa-Lyonnet D.
    Br J Cancer; 2000 Feb 16; 82(4):818-22. PubMed ID: 10732752
    [Abstract] [Full Text] [Related]

  • 4. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 16; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 5. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas.
    Saxena A, Robertson JT, Ali IU.
    Oncogene; 1996 Aug 01; 13(3):661-4. PubMed ID: 8760309
    [Abstract] [Full Text] [Related]

  • 6. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.
    Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW, Jenkins RB.
    Am J Med Genet; 2000 May 15; 92(2):136-41. PubMed ID: 10797439
    [Abstract] [Full Text] [Related]

  • 7. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
    Della Torre G, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot TJ, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G, Pierotti MA.
    Br J Cancer; 2001 Sep 14; 85(6):836-44. PubMed ID: 11556834
    [Abstract] [Full Text] [Related]

  • 8. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T, Tsunoda S, Sakaki T, Konishi N, Hiasa Y, Nakamura M.
    Cancer; 1996 Jul 15; 78(2):287-93. PubMed ID: 8674005
    [Abstract] [Full Text] [Related]

  • 9. Deletion and transfection analysis of the p15/MTS2 gene in malignant gliomas.
    Tenan M, Benedetti S, Finocchiaro G.
    Biochem Biophys Res Commun; 1995 Dec 05; 217(1):195-202. PubMed ID: 8526910
    [Abstract] [Full Text] [Related]

  • 10. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
    Tahara H, Smith AP, Gaz RD, Arnold A.
    J Clin Endocrinol Metab; 1996 Oct 05; 81(10):3663-7. PubMed ID: 8855819
    [Abstract] [Full Text] [Related]

  • 11. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
    Fuxe J, Akusjärvi G, Goike HM, Roos G, Collins VP, Pettersson RF.
    Cell Growth Differ; 2000 Jul 05; 11(7):373-84. PubMed ID: 10939591
    [Abstract] [Full Text] [Related]

  • 12. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.
    Invest Ophthalmol Vis Sci; 2002 Sep 05; 43(9):2845-51. PubMed ID: 12202501
    [Abstract] [Full Text] [Related]

  • 13. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T.
    Clin Cancer Res; 2003 Oct 15; 9(13):4884-90. PubMed ID: 14581362
    [Abstract] [Full Text] [Related]

  • 14. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA.
    Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779
    [Abstract] [Full Text] [Related]

  • 15. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P, Schmidt M, Hu X, Wolff L.
    Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863
    [Abstract] [Full Text] [Related]

  • 16. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
    Kurakawa E, Shimamoto T, Utsumi K, Hirano T, Kato H, Ohyashiki K.
    Int J Oncol; 2001 Aug 20; 19(2):277-81. PubMed ID: 11445839
    [Abstract] [Full Text] [Related]

  • 17. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G.
    Am J Pathol; 2001 Aug 20; 159(2):661-9. PubMed ID: 11485924
    [Abstract] [Full Text] [Related]

  • 18. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
    Chaussade L, Eymin B, Brambilla E, Gazzeri S.
    Oncogene; 2001 Oct 04; 20(45):6587-96. PubMed ID: 11641784
    [Abstract] [Full Text] [Related]

  • 19. A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16(INK4A)/p15(INK4B) tumor suppressor and immunoglobulin heavy chain genes: TGFbeta/IL-7 inhibitory signaling mechanism.
    Urashima M, Hoshi Y, Sugimoto Y, Kaihara C, Matsuzaki M, Chauhan D, Ogata A, Teoh G, DeCaprio JA, Anderson KC.
    Leukemia; 1996 Oct 04; 10(10):1576-83. PubMed ID: 8847892
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M, Kobayashi C, Setsu N, Takahashi Y, Kohashi K, Yamamoto H, Tamiya S, Matsuda S, Iwamoto Y, Tsuneyoshi M, Oda Y.
    Clin Cancer Res; 2011 Jun 01; 17(11):3771-82. PubMed ID: 21262917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.